Notice of Award of a Single Source Cooperative Agreement To Fund Elizabeth Glaser Pediatric AIDS Foundation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $750,000 for Federal Fiscal Year 2026 funding to Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), subject to the availability of funds. The award supports activities to improve HIV care and treatment for children and eliminate mother-to-child HIV transmission faster, working with faith-based organizations (FBOs), faith-affiliated health facilities, and community-based organizations (CBOs), which are trusted providers in many high-burden communities. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 165 (Thursday, August 27, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 165 (Thursday, August 27, 2026)]
[Notices]
[Pages 55346-55347]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-17449]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single Source Cooperative Agreement To Fund
Elizabeth Glaser Pediatric AIDS Foundation
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $750,000 for Federal Fiscal Year 2026 funding to
Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), subject to the
availability of funds. The award supports activities to improve HIV
care and treatment for children and eliminate mother-to-child HIV
transmission faster, working with faith-based organizations (FBOs),
faith-affiliated health facilities, and community-based organizations
(CBOs), which are trusted providers in many high-burden communities.
Funding amounts for years 2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2026, through
September 29, 2031.
FOR FURTHER INFORMATION CONTACT: Cristel Bender, Global Health Center,
Centers for Disease Control and Prevention, 1600 Clifton Rd. NE,
Atlanta, GA 30329, email: <a href="/cdn-cgi/l/email-protection#50141718041e1f161f23103334337e373f26"><span class="__cf_email__" data-cfemail="e4a0a3acb0aaaba2ab97a4878087ca838b92">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single source award supports activities
to improve HIV care and treatment for children and eliminate mother-to-
child HIV transmission faster, working with faith-based organizations
(FBOs), faith-affiliated health facilities, and community-based
organizations (CBOs), which are trusted providers in many high-burden
communities.
Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is in a unique
position to conduct this work, as it is a leading organization
dedicated to ending pediatric HIV/AIDS in the global space and has
demonstrated substantial and significant expertise and proven ability
to scale pediatric HIV prevention, treatment, and care programs
globally.
Summary of the Award
Recipient: Elizabeth Glaser Pediatric AIDS Foundation (EGPAF).
[[Page 55347]]
Purpose of the award: The purpose of this award is to create and
enhance local and sustainable approaches that address the gap in
pediatric HIV care by leveraging FBOs and CBOs to identify and treat
children living with HIV more quickly and prevent mother-to-child
transmission.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003) [22 U.S.C. 7601, et seq.] and Public Law 110-293 (the Tom
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), Public
Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013), and Section
307 of the Public Health Service Act (42 U.S.C. 242l).
Period of performance: September 30, 2026, through September 29,
2031.
Jamie Legier,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2026-17449 Filed 8-26-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.